National Cocaine, Meth & Stimulant Summit


January 2, 2018

For Immediate Release

Doug Edwards, Director, Institute for the Advancement of Behavioral Healthcare
216-373-1201 |

NEW YORK -- The Institute for the Advancement of Behavioral Healthcare announces the launch of the National Cocaine, Meth & Stimulant Summit to engage stakeholders across the country in discussions about this “twin epidemic” complicating the opioid crisis. The conference will be November 12-14, 2018, in Fort Lauderdale, Florida.

The opioid crisis is making headlines, but another category of drugs continues to devastate communities: stimulants. Cocaine is flooding Southern states as production increases to record levels in South America. Meth remains an omnipresent scourge. And college students across the country continue to misuse prescription drugs to boost academic performance. Together these “twin epidemics” are overwhelming law enforcement and treatment providers.

Yet there are many reasons for hope, as this crisis is not going unnoticed. Clinical professionals, whether part of larger systems or in private practice, are in an ideal position to discuss with their clients why stimulants are no less dangerous than opioids, as well as address the trauma and shame histories that often lead to substance use. Law enforcement officials are taking steps to educate their teams and communities about effective strategies for removing these drugs from the streets. And multiple stakeholders are working together to prevent stimulant use, provide access to treatment, and ensure that stimulants are part of larger societal discussions about addressing drug use.

“The National Cocaine, Meth & Stimulant Summit will be the ideal venue to convene stakeholder conversations about addressing stimulant use, particularly during our national opioid crisis,” said Doug Edwards, director of the Institute.

The Institute convenes several regional summits on the opioid crisis as well as the National Rx Drug Abuse& Heroin Summit, where President Obama addressed attendees in 2016 and the U.S. Secretary of Health and Human Services addressed attendees in 2017, as well as the National Conference on Addiction Disorders. Dominion Diagnostics (, a long-time partner of the Institute and leading supporter of the Rx Summit and NCAD, will be one of the founding sponsors of the new Stimulant Summit.

For more details on the National Cocaine, Meth & Stimulant Summit, see To sign up for updates on the conference and news related to stimulants, visit

About the Institute for the Advancement of Behavioral Healthcare

The Institute for the Advancement of Behavioral Healthcare is the leading education provider to behavioral healthcare professionals and allied stakeholders. Our wide range of resources includes two award-winning publications, Addiction Professional and Behavioral Healthcare Executive; national and regional conferences; local lunch’n’learns and virtual Webinars; and topic-focused e-newsletters. The Institute continuously engages more than 200,000 professionals, including front-line clinicians and private-practice therapists; nurses, physicians, and other medical professionals; and executive-level decision makers at a wide range of for-profit, not-for-profit, public, and private mental health and substance use treatment organizations. The Institute also leads discussions among policy makers, prevention and public health officials, law enforcement personnel, and community advocates. For more information, visit